Biomarkers of cardiac disease
نویسندگان
چکیده
منابع مشابه
Cardiac Biomarkers for Early Detection of Cardiac Involvement in Children with Kawasaki Disease: A Cross-Sectional Study
Background: Kawasaki disease (KD) is one of the most prevalent vasculitis diseases in children and can bring about serious cardiovascular complications. Early detection of cardiac involvement in KD can play an essential role in managing and preventing the cardiac sequels. We aimed to evaluate the applicability and diagnostic accuracy of cardiac biomarkers including car...
متن کاملBiomarkers in Acute Cardiac Disease
The use of biomarkers to aid diagnosis and treatment is increasing rapidly as genomics and proteomics help us expand the number of markers we can use and as an improved understanding of the pathophysiology of cardiac disease guides their use. However, as with all rapidly expanding fields, there is the risk of excessive enthusiasm unless we are circumspect about the data that guide the clinical ...
متن کاملBiomarkers in acute cardiac disease.
In their state-of-the-art paper on biomarkers in acute cardiac disease (1), Dr. Jaffe and colleagues list creatine kinase-MB (CK-MB) as a “potentially outdated marker.” However, CK-MB has a specific utility in the diagnosis of reinfarction (2), and it cannot be replaced by the cardiac troponins for this purpose. By following up the time course of rise and fall of CK-MB, an interruption in the p...
متن کاملDiagnostic and Prognostic Value of Cardiac Biomarkers in Children with Kawasaki Disease: A State-of-the-Art Review
Kawasaki disease (KD) is characterized as the leading cause of acquired cardiac disease in children. Accurate and timely diagnosis of KD is of high importance for preventing its cardiac complications. However, diagnosis merely based on clinical findings has a number of challenges and, limitations. Therefore, researchers are investigating to find more object...
متن کاملCardiac Biomarkers in End-Stage Renal Disease
Patients with end-stage renal disease (ESRD) often suffer from cardiovascular complications and comorbidities. For example, 55% of ESRD patients suffer from congestive heart failure (CHF) and cardiovascular diseases account for the majority of deaths among ESRD patients (Herzog, Ma, & Collins, 1998; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases;...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Southern African Journal of Anaesthesia and Analgesia
سال: 2011
ISSN: 2220-1181,2220-1173
DOI: 10.1080/22201173.2011.10872752